Clinical Trials Browser

Phase 1 × Malignant Solid Tumour × Dasatinib × Clear all

NCT00388427 2015-05-28

Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour